Stephen H Friend Selected Research

Cisplatin (Platino)

12/2006

Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen H Friend Research Topics

Disease

3	Neoplasms (Cancer) 07/2015 - 05/2006
2	Type 2 Diabetes Mellitus (MODY) 05/2022 - 01/2017
2	Neoplasm Metastasis (Metastasis) 12/2002 - 01/2002
2	Breast Neoplasms (Breast Cancer) 12/2002 - 01/2002
1	Body Weight (Weight, Body) 05/2022
1	Insulin Resistance 05/2022
1	Glucose Intolerance 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Cognitive Dysfunction 01/2016
1	Microsatellite Instability 11/2015
1	Disease Progression 07/2015

Drug/Important Bio-Agent (IBA)

2	Blood Glucose (Blood Sugar)IBA 05/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 05/2006
1	sulforaphaneIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015
1	NucleotidesIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 12/2006
1	Small Interfering RNA (siRNA)IBA 12/2006
1	Tumor Biomarkers (Tumor Markers)IBA 05/2006
1	Dihydrotachysterol (AT 10)IBA 12/2002
1	DNA (Deoxyribonucleic Acid)IBA 01/2002

Therapy/Procedure

5	Therapeutics 01/2016 - 01/2002
1	Glycemic Control 05/2022
1	Drug Therapy (Chemotherapy) 01/2002